Nocturnal Hypoxemic Burden and Micro- and Macrovascular Disease in Patients with Type 2 Diabetes

Overview

Journal Cardiovasc Diabetol

Publisher Biomed Central

Specialties Cardiology & Vascular Diseases
Endocrinology

Date 2024 Jun 6

PMID 38844945

Authors

Sarah Driendl

Stefan Stadler

Michael Arzt

Florian Zeman

Iris M Heid

Mathias Baumert

Affiliations

Soon will be listed here.

Abstract

Background: Micro- and macrovascular diseases are common in patients with type 2 diabetes mellitus (T2D) and may be partly caused by nocturnal hypoxemia. The study aimed to characterize the composition of nocturnal hypoxemic burden and to assess its association with micro- and macrovascular disease in patients with T2D.

Methods: This cross-sectional analysis includes overnight oximetry from 1247 patients with T2D enrolled in the DIACORE (DIAbetes COhoRtE) study. Night-time spent below a peripheral oxygen saturation of 90% (T90) as well as T90 associated with non-specific drifts in oxygen saturation (T90), T90 associated with acute oxygen desaturation (T90) and desaturation depths were assessed. Binary logistic regression analyses adjusted for known risk factors (age, sex, smoking status, waist-hip ratio, duration of T2D, HbA1c, pulse pressure, low-density lipoprotein, use of statins, and use of renin-angiotensin-aldosterone system inhibitors) were used to assess the associations of such parameters of hypoxemic burden with chronic kidney disease (CKD) as a manifestation of microvascular disease and a composite of cardiovascular diseases (CVD) reflecting macrovascular disease.

Results: Patients with long T90 were significantly more often affected by CKD and CVD than patients with a lower hypoxemic burden (CKD 38% vs. 28%, p < 0.001; CVD 30% vs. 21%, p < 0.001). Continuous T90 and desaturation depth were associated with CKD (adjusted OR 1.01 per unit, 95% CI [1.00; 1.01], p = 0.008 and OR 1.30, 95% CI [1.06; 1.61], p = 0.013, respectively) independently of other known risk factors for CKD. For CVD there was a thresholdeffect, and only severly and very severly increased T90 was associated with CVD ([Q3;Q4] versus [Q1;Q2], adjusted OR 1.51, 95% CI [1.12; 2.05], p = 0.008) independently of other known risk factors for CVD.

Conclusion: While hypoxemic burden due to oxygen desaturations and the magnitude of desaturation depth were significantly associated with CKD, only severe hypoxemic burden due to non-specific drifts was associated with CVD. Specific types of hypoxemic burden may be related to micro- and macrovascular disease.

References

Xia W, Huang Y, Peng B, Zhang X, Wu Q, Sang Y . Relationship between obstructive sleep apnoea syndrome and essential hypertension: a dose-response meta-analysis. Sleep Med. 2018; 47:11-18. DOI: 10.1016/j.sleep.2018.03.016. View

Azarbarzin A, Sands S, Taranto-Montemurro L, Vena D, Sofer T, Kim S . The Sleep Apnea-Specific Hypoxic Burden Predicts Incident Heart Failure. Chest. 2020; 158(2):739-750. PMC: 7417383. DOI: 10.1016/j.chest.2020.03.053. View

Marrone O, Battaglia S, Steiropoulos P, Basoglu O, Kvamme J, Ryan S . Chronic kidney disease in European patients with obstructive sleep apnea: the ESADA cohort study. J Sleep Res. 2016; 25(6):739-745. DOI: 10.1111/jsr.12426. View

Erman M, Stewart D, Einhorn D, Gordon N, Casal E . Validation of the ApneaLink for the screening of sleep apnea: a novel and simple single-channel recording device. J Clin Sleep Med. 2007; 3(4):387-92. PMC: 1978315. View

Lee Y, Hung S, Wang H, Lin C, Wang H, Chen S . Sleep apnea and the risk of chronic kidney disease: a nationwide population-based cohort study. Sleep. 2014; 38(2):213-21. PMC: 4288602. DOI: 10.5665/sleep.4400. View

Prabhakar N, Semenza G . Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2. Physiol Rev. 2012; 92(3):967-1003. PMC: 3893888. DOI: 10.1152/physrev.00030.2011. View

Morrish N, Wang S, Stevens L, Fuller J, Keen H . Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia. 2001; 44 Suppl 2:S14-21. DOI: 10.1007/pl00002934. View

Huang H, Walters G, Talaulikar G, Figurski D, Carroll A, Hurwitz M . Sleep apnea prevalence in chronic kidney disease - association with total body water and symptoms. BMC Nephrol. 2017; 18(1):125. PMC: 5381077. DOI: 10.1186/s12882-017-0544-3. View

Wang B, Li Z, Zhang Y, Wen Y, Gao Y, Liu B . Hypoxia and chronic kidney disease. EBioMedicine. 2022; 77:103942. PMC: 8921539. DOI: 10.1016/j.ebiom.2022.103942. View

10.

Puthenpura M, Hansrivijit P, Ghahramani N, Thongprayoon C, Cheungpasitporn W . Chronic kidney disease and concomitant sleep apnea are associated with increased overall mortality: a meta-analysis. Int Urol Nephrol. 2020; 52(12):2337-2343. DOI: 10.1007/s11255-020-02583-y. View

11.

Ryan S . Mechanisms of cardiovascular disease in obstructive sleep apnoea. J Thorac Dis. 2019; 10(Suppl 34):S4201-S4211. PMC: 6321896. DOI: 10.21037/jtd.2018.08.56. View

12.

Oldenburg O, Wellmann B, Buchholz A, Bitter T, Fox H, Thiem U . Nocturnal hypoxaemia is associated with increased mortality in stable heart failure patients. Eur Heart J. 2015; 37(21):1695-703. DOI: 10.1093/eurheartj/ehv624. View

13.

Li X, Liu C, Zhang H, Zhang J, Zhao M, Sun D . Effect of 12-month nasal continuous positive airway pressure therapy for obstructive sleep apnea on progression of chronic kidney disease. Medicine (Baltimore). 2019; 98(8):e14545. PMC: 6407975. DOI: 10.1097/MD.0000000000014545. View

14.

Yamauchi M, Nakano H, Maekawa J, Okamoto Y, Ohnishi Y, Suzuki T . Oxidative stress in obstructive sleep apnea. Chest. 2005; 127(5):1674-9. DOI: 10.1378/chest.127.5.1674. View

15.

Dorhofer L, Lammert A, Krane V, Gorski M, Banas B, Wanner C . Study design of DIACORE (DIAbetes COhoRtE) - a cohort study of patients with diabetes mellitus type 2. BMC Med Genet. 2013; 14:25. PMC: 3577512. DOI: 10.1186/1471-2350-14-25. View

16.

Lin C, Lurie R, Lyons O . Sleep Apnea and Chronic Kidney Disease: A State-of-the-Art Review. Chest. 2019; 157(3):673-685. DOI: 10.1016/j.chest.2019.09.004. View

17.

Kious K, Savage K, Twohey S, Highum A, Philipose A, Diaz H . Chronic intermittent hypoxia promotes glomerular hyperfiltration and potentiates hypoxia-evoked decreases in renal perfusion and PO. Front Physiol. 2023; 14:1235289. PMC: 10358516. DOI: 10.3389/fphys.2023.1235289. View

18.

Dong J, Zhang Y, Qin L . Obstructive sleep apnea and cardiovascular risk: meta-analysis of prospective cohort studies. Atherosclerosis. 2013; 229(2):489-95. DOI: 10.1016/j.atherosclerosis.2013.04.026. View

19.

Tahrani A, Ali A, Raymond N, Begum S, Dubb K, Altaf Q . Obstructive sleep apnea and diabetic nephropathy: a cohort study. Diabetes Care. 2013; 36(11):3718-25. PMC: 3816897. DOI: 10.2337/dc13-0450. View

20.

Sakaguchi Y, Hatta T, Hayashi T, Shoji T, Suzuki A, Tomida K . Association of nocturnal hypoxemia with progression of CKD. Clin J Am Soc Nephrol. 2013; 8(9):1502-7. PMC: 3805083. DOI: 10.2215/CJN.11931112. View